Dhampur Bio Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
40.00
17.00
65.00
134.00
129.00
0.00
Adjustment
119.00
121.00
77.00
76.00
60.00
0.00
Changes In working Capital
58.00
-1.00
-227.00
179.00
-413.00
0.00
Cash Flow after changes in Working Capital
218.00
138.00
-83.00
390.00
-223.00
0.00
Cash Flow from Operating Activities
219.00
129.00
-101.00
368.00
-246.00
0.00
Cash Flow from Investing Activities
-41.00
-145.00
-166.00
-208.00
-123.00
0.00
Cash Flow from Financing Activities
-178.00
18.00
169.00
-78.00
393.00
0.00
Net Cash Inflow / Outflow
0.00
2.00
-98.00
81.00
22.00
0.00
Opening Cash & Cash Equivalents
8.00
5.00
104.00
22.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
8.00
8.00
5.00
104.00
22.00
0.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Dhampur Bio
Figures in Cr
standaloned Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
40.29
52.46
-12.00
-23.20%
Adjustment
116.93
64.6
52.00
81.01%
Changes In working Capital
59.14
-44.16
103.00
233.92%
Cash Flow after changes in Working Capital
216.36
72.9
144.00
196.79%
Cash Flow from Operating Activities
217.95
60.68
157.00
259.18%
Cash Flow from Investing Activities
-41.88
-6.55
-35.00
-539.39%
Cash Flow from Financing Activities
-178.47
27.33
-205.00
-753.02%
Net Cash Inflow / Outflow
-2.4
81.45
-83.00
-102.95%
Opening Cash & Cash Equivalents
6.9
0.57
6.00
1110.53%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
4.5
82.02
-78.00
-94.51%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 69.68% vs 227.87% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
219.86
129.57
69.68%






